Table 1.
Inclusion criteria of the present meta-analysis. ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Inclusion Criteria | Description |
---|---|
Population | Patients with chronic liver disease |
Intervention | Taking the target drugs, including carnitine-orotate, carnitine-orotate complex, and L-carnitine |
Comparison | No target drugs |
Outcomes | Proportion of patients with ALT normalization or difference in post-treatment serum AST and ALT levels |
Study design | Randomized controlled trial |